Aptamers targeting rabies virus-infected cells inhibit viral replication both in vitro and in vivo

Virus Research

Volumn 173, Issue 2, 2013, Pages 398-403

  Liang, Hong Ru ^a,b   Liu, Quan ^a   Zheng, Xue Xing ^a   Gai, Wei Wei ^a   Xue, Xiang hong ^a,b   Hu, Gui Qiu ^a   Wu, Hong Xia ^a   Wang, Hua Lei ^a   Yang, Song Tao ^a   Xia, Xian Zhu ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Antiviral activity; Aptamer; Rabies virus

Indexed keywords

APTAMER; FO 21 APTAMER; FO 24 APTAMER; SINGLE STRANDED DNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANINE DISTEMPER MORBILLIVIRUS; CONTROLLED STUDY; FELINE PANLEUKOPENIA VIRUS; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; LETHAL DOSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABIES VIRUS; RHABDOVIRUS INFECTION; SURVIVAL RATE; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS TITRATION; WEIGHT REDUCTION;

ANIMALS; ANTIVIRAL AGENTS; APTAMERS, NUCLEOTIDE; DISEASE MODELS, ANIMAL; DISTEMPER VIRUS, CANINE; FEMALE; MICE; MICE, INBRED BALB C; PARVOVIRUS, CANINE; RABIES; RABIES VIRUS; SURVIVAL ANALYSIS; VIRAL LOAD; VIRUS REPLICATION;

CANINE DISTEMPER VIRUS; CANINE PARVOVIRUS; MAMMALIA; MUS; RABIES VIRUS;

EID: 84876820041     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2012.12.017     Document Type: Article

References (21)

1. Allendorf S.D., Cortez A., Heinemann M.B., Harary C.M., Antunes J.M., Peres M.G., et al. Rabies virus distribution in tissues and molecular characterization of strains from naturally infected non-hematophagous bats. Virus Research 2012, 165:119-125.
2. Binning J.M., Leung D.W., Amarasinghe G.K. Aptamers in virology: recent advances and challenges. Frontiers in Microbiology 2012, 3:29.
3. Bouchard P.R., Hutabarat R.M., Thompson K.M. Discovery and development of therapeutic aptamers. Annual Review of Pharmacology and Toxicology 2010, 50:237-257.
4. Chopy D., Pothlichet J., Lafage M., Megret F., Fiette L., Si-Tahar M., et al. Ambivalent role of the innate immune response in rabies virus pathogenesis. Journal of Virology 2011, 85:6657-6668.
5. Dietzschold B., Schnell M., Koprowski H. Pathogenesis of rabies. Current Topics in Microbiology and Immunology 2005, 292:45-56.
6. Farokhzad O.C., Cheng J., Teply B.A., Sherifi I., Jon S., Kantoff P.W., et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:6315-6320.
7. Franka R., Wu X., Jackson F.R., Velasco-Villa A., Palmer D.P., Henderson H., et al. Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies vaccines. Vaccine 2009, 27:7149-7155.
8. Jeon S.H., Kayhan B., Ben-Yedidia T., Arnon R.A. DNA aptamer prevents influenza infection by blocking the receptor binding region of the viral hemagglutinin. The Journal of Biological Chemistry 2004, 279:48410-48419.
9. Johnson N., Cunningham A.F., Fooks A.R. The immune response to rabies virus infection and vaccination. Vaccine 2010, 28:3896-3901.
10. Khati M. The future of aptamers in medicine. Journal of Clinical Pathology 2010, 63:480-487.
11. Kunii T., Ogura S., Mie M., Kobatake E. Selection of DNA aptamers recognizing small cell lung cancer using living cell-SELEX. The Analyst 2011, 136:1310-1312.
12. Liang H.R., Hu G.Q., Zhang T., Yang Y.J., Zhao L.L., Qi Y.L., et al. Isolation of ssDNA aptamers that inhibit rabies virus. International Immunopharmacology 2012, 14:341-347.
13. Roy A., Phares T.W., Koprowski H., Hooper D.C. Failure to open the blood-brain barrier and deliver immune effectors to central nervous system tissues leads to the lethal outcome of silver-haired bat rabies virus infection. Journal of Virology 2007, 81:1110-1118.
14. Shangguan D., Li Y., Tang Z., Cao Z.C., Chen H.W., Mallikaratchy P., et al. Aptamers evolved from live cells as effective molecular probes for cancer study. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:11838-11843.
15. Sunden Y., Yano S., Ishida S., Ochiai K., Umemura T. Intracerebral vaccination suppresses the spread of rabies virus in the mouse brain. Microbes and Infection/Institut Pasteur 2010, 12:1163-1169.
16. Wang P., Yang Y., Hong H., Zhang Y., Cai W., Fang D. Aptamers as therapeutics in cardiovascular diseases. Current Medicinal Chemistry 2011, 18:4169-4174.
17. Wirblich C., Schnell M.J. Rabies virus (RV) glycoprotein expression levels are not critical for pathogenicity of RV. Journal of Virology 2011, 85:697-704.
18. Yan A.C., Bell K.M., Breeden M.M., et al. Aptamers prospects in therapeutics and biomedicine. Frontiers in Bioscience 2005, 10:1802-1827.
19. Zandi F., Eslami N., Soheili M., Fayaz A., Gholami A., Vaziri B. Proteomics analysis of BHK-21 cells infected with a fixed strain of rabies virus. Proteomics 2009, 9:2399-2407.
20. Zhang W., Ke W., Wu S.S., Gan L., Zhou R., Sun C.Y., et al. An adenovirus-delivered peptide aptamer C1-1 targeting the core protein of hepatitis B virus inhibits viral DNA replication and production in vitro and in vivo. Peptides 2009, 30:1816-1821.
21. Zhang K., Sefah K., Tang L., Zhao Z., Zhu G., Ye M., et al. A novel aptamer developed for breast cancer cell internalization. ChemMedChem 2012, 7:79-84.